By Lachin Hatemi M.D.
M. Edward “Ed” Sellers is one of the most influential figures in the modern history of South Carolina’s healthcare system. A Kentucky native and graduate of Vanderbilt University and Harvard Business School, Sellers arrived in South Carolina after working for Westinghouse Electric, Boston Consulting Group and the Blue Cross and Blue Shield Association in Chicago. He joined BlueCross BlueShield of South Carolina in 1987 as president and chief operating officer. He was elected to the company’s board in 1989, became CEO in 1992 and was named chairman in 2001.
Sellers led the company during an extraordinary period of expansion. When he joined BlueCross in 1987, the company reported approximately $220 million in revenue and 3,000 employees. By the time he retired as CEO in 2010, revenue had increased to approximately $3.8 billion and employment had grown to about 11,000 people. The company had also expanded well beyond traditional health insurance into government contracting, Medicare and TRICARE administration, life insurance, property and casualty insurance, technology and other businesses.
David S. Pankau succeeded Sellers as president and CEO on August 1, 2010. But Sellers did not disappear from the organization. When he stepped down as CEO, the company announced that he would continue as chairman of the board.
Sixteen Years Later, Sellers Still Has a Seat at the Table
That continued involvement is remarkable.
Ed Seller occupies a seat as one of the directors of the 10 member board, a voting position which needs to be elected every year and pays a significant salary. Ironically, most policy holders would not even recognize Ed Seller’s name.
Publicly available records show that Sellers remains chairman/director of the BlueCross BlueShield of South Carolina Foundation. The Foundation’s most recent publicly reported financial information shows approximately $357.7 million in net assets at the end of 2024, with approximately $21.4 million in charitable grants and distributions during 2024. Sellers is listed as chairman/director, alongside executives including Erika Kirby and Michael Mizeur.
The Foundation is not a small charitable organization. It has become a significant institution in South Carolina healthcare philanthropy. Its stated mission is to support nonprofit organizations, government agencies and educational institutions working to improve health outcomes throughout the state. Since 2003, it says it has awarded more than 724 grants and supported more than 281 nonprofit organizations.
This gives Sellers influence extending beyond the insurance company’s traditional business operations. Through philanthropy, board relationships and the broader BlueCross corporate structure, a former CEO who retired from his executive position more than a decade ago remains connected to institutions that influence healthcare policy, nonprofit organizations and healthcare initiatives across South Carolina.
A Corporate Empire Much Larger Than an Insurance Company
It is important to understand what BlueCross BlueShield of South Carolina actually is.
The organization describes itself as a mutual insurance company. Its own provider manual states that BlueCross is a mutual insurer headquartered in Columbia, South Carolina. The company evolved into a mutual insurance organization after South Carolina repealed the legislation that had originally created BlueCross and BlueShield in 1969. The two organizations subsequently merged in 1971.
Regulatory documents have described the company as being owned by its policyholders.
That ownership structure raises an important public-policy question: How much influence should a former chief executive retain over an organization that ultimately exists to serve its policyholders?
Sellers’ continuing role makes that question particularly relevant.
He is not simply a retired executive appearing at occasional corporate events. Public records continue to identify him as chairman/director of the BlueCross BlueShield of South Carolina Foundation, while corporate and industry organizations have continued to identify him in leadership or emeritus positions associated with the BlueCross organization. For example, CGS Administrators’ board information identifies Sellers as chairman emeritus of the BlueCross BlueShield of South Carolina board.
The Larger Question: What Kind of Healthcare System Did Sellers Help Build?
Sellers’ supporters can point to an impressive record of corporate growth. Under his leadership, BlueCross expanded from a relatively small regional insurer into a multibillion-dollar enterprise with thousands of employees and extensive government-contracting operations.
But corporate growth and healthcare outcomes are not necessarily the same thing.
South Carolina continues to face significant challenges involving access to primary care, physician shortages, rural healthcare access, hospital consolidation and the financial viability of independent medical practices.
That creates a legitimate question for policymakers and the public:
Did the business model developed during the Sellers era ultimately strengthen South Carolina’s healthcare system—or did it contribute to a system increasingly dominated by large insurers and large hospital systems?
One particularly important area for investigation is the relationship between insurance reimbursement and the survival of independent physician practices.
Independent physicians frequently argue that reimbursement negotiations are not conducted on a level playing field. A large insurer negotiating with a small physician-owned practice possesses substantially greater economic leverage. If reimbursement rates are significantly lower for independent practices than for large health systems or affiliated organizations, independent practices may eventually find it difficult to remain financially viable.
That issue deserves examination through actual claims data rather than rhetoric.
For example, policymakers should examine reimbursement rates paid by BlueCross to physician-owned practices compared with rates paid to hospital-owned practices for identical CPT codes and identical services. They should examine network participation, reimbursement disparities, facility fees, professional fees and the economic consequences of different contracting arrangements.
If significant differences exist, the next question should be why.
The Allegations Deserve Evidence—Not Dismissal
There are serious allegations that BlueCross reimbursement and network policies have disadvantaged independent physician practices and encouraged consolidation of healthcare into larger hospital systems.
However, Sellers’ extraordinary longevity at the highest levels of the organization makes his leadership record an appropriate subject of public examination.
If the policies that shaped today’s healthcare marketplace were developed during his tenure, then understanding the Sellers era is essential to understanding how South Carolina arrived at its current healthcare environment.
The investigation should therefore focus on measurable facts:
What did BlueCross pay independent physicians compared with hospital-owned practices?
Were physicians excluded from networks for reasons unrelated to quality or cost?
How did reimbursement rates change over the Sellers and Pankau eras?
Did reimbursement policies contribute to the closure or sale of independent medical practices?
Did BlueCross contracts create economic incentives favoring particular healthcare systems?
How much did BlueCross spend on physician reimbursement versus administrative expenses?
What compensation and deferred-compensation arrangements were established for senior executives?
Who approved those arrangements?
What role did the board play?
And ultimately, did these policies serve the interests of BlueCross policyholders?
These questions can be answered with contracts, claims data, financial statements, board records and regulatory filings.
The Executive Compensation Question
Another issue that warrants careful examination is executive compensation and deferred compensation.
There have been concerns about a large “Rabbi Trust” or deferred-compensation arrangement involving senior BlueCross executives. This $450 million in deferred compensation should be investigated by legislators and SCDOI.
That distinction matters.
If a $450 million executive deferred-compensation structure exists, the public deserves to know its precise terms, beneficiaries, funding mechanism and approval process. But those facts should be established through audited financial statements, regulatory filings or the underlying trust documents rather than presented as established fact without supporting documentation.
The Power of Institutional Longevity
Perhaps the most unusual aspect of Sellers’ career is not simply how long he served as CEO. It is how long his influence has continued after leaving the CEO’s office.
He led BlueCross for 18 years as CEO and remained chairman after retiring from the chief executive position. More than a decade later, public records still identify him as chairman/director of the organization’s Foundation.
That kind of institutional continuity is unusual in corporate America.
It also creates a legitimate governance question.
When the same individual remains connected to an organization for decades, the issue is no longer simply whether that person has formal executive authority. It is also whether informal relationships, institutional knowledge, board relationships and personal influence continue to shape decision-making.
Sellers’ supporters might describe that continuity as experience and institutional stability.
Critics might describe it as excessive concentration of influence.
Both interpretations deserve to be tested against the facts.
South Carolina Needs Transparency, Not Personalities
The debate over Ed Sellers should ultimately not be about whether one elderly retired executive is personally responsible for every problem in South Carolina healthcare.
That would oversimplify a complicated system.
The more important question is whether the governance and business practices developed over decades have produced the healthcare marketplace South Carolina needs today.
BlueCross is enormously influential in the state. Its decisions affect physicians, hospitals, employers, patients and taxpayers. Its Foundation controls hundreds of millions of dollars in assets and distributes tens of millions of dollars to organizations throughout South Carolina.
That level of institutional influence demands transparency.
South Carolinians should be able to understand who makes the decisions, how those decisions are made, how executives are compensated, how provider reimbursement is determined and whether the system treats independent physicians and large healthcare organizations fairly.
Ed Sellers’ five-decade association with BlueCross makes him an important figure in that history.
But the goal should not be to replace one personality with another.
The goal should be to build a healthcare system in which policyholders, patients and physicians—not institutional insiders—have the strongest voice.
If South Carolina wants to improve healthcare access, preserve independent medical practices and reduce unnecessary consolidation, it needs to examine the financial and governance structures that brought the state to its current position.
And that examination should include the Sellers era, the policies established during his tenure, and the influence that remains today.
No comments:
Post a Comment